Latanoprost and Poor venous access - a phase IV clinical study of FDA data

Summary:

Poor venous access is reported as a side effect among people who take Latanoprost (latanoprost), especially for people who are female, 60+ old, also take Acetaminophen, and have Immunodeficiency.

The phase IV clinical study analyzes which people have Poor venous access when taking Latanoprost. It is created by eHealthMe based on reports of 32,842 people who have side effects when taking Latanoprost from the FDA, and is updated regularly.

What is Latanoprost?

Latanoprost has active ingredients of latanoprost. It is often used in glaucoma. eHealthMe is studying from 33,249 Latanoprost users. Check the latest studies of Latanoprost.

What is Poor venous access?

Poor venous access is found to be associated with 673 drugs and 479 conditions by eHealthMe. Check the latest studies of Poor venous access.

On Jul, 06, 2026

32,842 people reported to have side effects when taking Latanoprost.
Among them, 15 people (0.05%) have Poor venous access.

Could Latanoprost cause Poor venous access?

Among these 15 people:

What is the gender of people who have Poor venous access when taking Latanoprost? *

female: 93.33 %
male: 6.67 %

What is the age of people who have Poor venous access when taking Latanoprost? *

What are other drugs people take besides Latanoprost? *

What are other side effects people have besides Poor venous access? *

Infusion Site Extravasation (flow of (blood or lymph) from infusion site): 7 people, 46.67%
Rashes (redness): 6 people, 40.00%
Consciousness - Decreased: 6 people, 40.00%
Dermatitis Contact (skin reaction (dermatitis) resulting from exposure to allergens): 6 people, 40.00%
Nausea (feeling of having an urge to vomit): 6 people, 40.00%
Peripheral Swelling: 6 people, 40.00%
Pneumonia: 6 people, 40.00%
Abdominal Discomfort: 6 people, 40.00%
Serotonin Syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time): 6 people, 40.00%
Dermal Cyst: 5 people, 33.33%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 40.00%
Primary Immunodeficiency Syndrome: 6 people, 40.00%
Immunodeficiency: 6 people, 40.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 13.33%
Immunodeficiency Common Variable: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Latanoprost and have Poor venous access?

- Check whether Poor venous access is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Latanoprost:

Latanoprost (33,249 reports)

Browse all side effects of Latanoprost:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Poor venous access:

Poor venous access (673 drugs)

Browse all the conditions that are associated with Poor venous access:

Poor venous access (479 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on latanoprost (the active ingredients of Latanoprost) and Latanoprost (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.